Vanguard Global Advisers
MD icon

Vanguard Global Advisers’s Pediatrix Medical MD Stock Holding History

Vanguard Global Advisers’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.24M Sell
88,425
-36,454
-29% -$829K ﹤0.01% 1179
2026
Q1 		$2.67M Buy
+124,879
New +$2.6M ﹤0.01% 1018

Other funds holding MD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Vanguard Global Advisers's MD Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Pediatrix Medical (MD) stake by 29% in Q2 2026, selling an estimated $829K and leaving 88,425 shares worth $2.24M. The position accounts for ﹤0.01% of the portfolio, ranked #1179.

Vanguard Global Advisers first reported a position in MD in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.67M in Q1 2026. 300 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Vanguard Global Advisers held 88,425 shares of Pediatrix Medical worth $2.24M as of Q2 2026.
  • Vanguard Global Advisers sold 36,454 Pediatrix Medical shares in Q2 2026, an estimated $829K.
  • Pediatrix Medical made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #1179 holding.
  • Vanguard Global Advisers first reported a position in Pediatrix Medical in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Pediatrix Medical position peaked at $2.67M in Q1 2026.
  • 300 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.